(주)지넥스바이오

{
  "address": "충청남도 아산시",
  "ceo_name": "이병열",
  "certificate": [
    {
      "cert_number": "20200102297",
      "changes": "",
      "disclosure_date": "2020-03-03",
      "first_cert_date": "2020-03-03",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-03-03 ~ 2022-03-02"
    },
    {
      "cert_number": "20220428030017",
      "changes": "",
      "disclosure_date": "2022-04-28",
      "first_cert_date": "2020-03-03",
      "no": "2",
      "type": "혁신성장유형",
      "valid_period": "2022-03-03 ~ 2025-03-02"
    },
    {
      "cert_number": "20250401030128",
      "changes": "",
      "disclosure_date": "2025-04-01",
      "first_cert_date": "2020-03-03",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2025-03-03 ~ 2028-03-02"
    }
  ],
  "company_name": "(주)지넥스바이오",
  "corp_no": "161511-*******",
  "financials": {
    "2022": {
      "capital_stock": 200000000,
      "cost_of_sales": 81983000,
      "current_assets": 431619000,
      "current_liabilities": 281675000,
      "gross_profit": 233810000,
      "net_income": 56568000,
      "net_income_bs": 56568000,
      "non_current_assets": 778080000,
      "non_current_liabilities": 643290000,
      "non_operating_expenses": 7962000,
      "non_operating_income": 19909000,
      "operating_profit": 44621000,
      "revenue": 315793000,
      "sga_expenses": 189189000,
      "total_assets": 1209699000,
      "total_equity": 284734000,
      "total_liabilities": 924965000
    },
    "2023": {
      "capital_stock": 200000000,
      "cost_of_sales": 23512000,
      "current_assets": 539852000,
      "current_liabilities": 340372000,
      "gross_profit": 287373000,
      "net_income": 16295000,
      "net_income_bs": 15728000,
      "non_current_assets": 790712000,
      "non_current_liabilities": 689730000,
      "non_operating_expenses": 22165000,
      "non_operating_income": 61783000,
      "operating_profit": -23323000,
      "revenue": 310885000,
      "sga_expenses": 310696000,
      "total_assets": 1330564000,
      "total_equity": 300462000,
      "total_liabilities": 1030102000
    },
    "2024": {
      "capital_stock": 200000000,
      "cost_of_sales": 24384000,
      "current_assets": 541655000,
      "current_liabilities": 338609000,
      "gross_profit": 284829000,
      "net_income": 11885000,
      "net_income_bs": 11685000,
      "non_current_assets": 1018301000,
      "non_current_liabilities": 909200000,
      "non_operating_expenses": 25402000,
      "non_operating_income": 601000,
      "operating_profit": 36686000,
      "revenue": 309213000,
      "sga_expenses": 248143000,
      "total_assets": 1559956000,
      "total_equity": 312147000,
      "total_liabilities": 1247809000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "연구개발, 무기화합물, 기타 가공품, 응용소프트웨어 개발 공급",
  "phone": "041-541-****",
  "years": [
    2024,
    2023,
    2022
  ]
}